MYC and non-small cell lung carcinoma: For example, in non-small-cell lung cancer, downregulation of USP13 suppresses ATK/MAPK signaling, reducing c-Myc protein levels and retards tumor growth both in tumor cells and nude mice (Wu et al., 2019).